Vadodara News Flash

Progressive Supranuclear Palsy Market Size, Share, Trend, Epidemiology & Market Forecast to 2030

 Breaking News
  • No posts were found

Progressive Supranuclear Palsy Market Size, Share, Trend, Epidemiology & Market Forecast to 2030

March 27
20:46 2020
Progressive Supranuclear Palsy Market Size, Share, Trend, Epidemiology & Market Forecast to 2030

Delveinsight Business Research
DelveInsight’s “Progressive Supranuclear Palsy Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Progressive Supranuclear Palsy, historical and forecasted epidemiology as well as the Progressive Supranuclear Palsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Progressive Supranuclear Palsy market report covers emerging drugs, current treatment practices, Progressive Supranuclear Palsy market share of the individual therapies, current and forecasted Progressive Supranuclear Palsy Market Size from 2017 to 2030 segmented by seven major markets. 

The report also provides detailed current Progressive Supranuclear Palsy treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. 

 

Progressive Supranuclear Palsy Market Key Facts

As per the study conducted by Viscidi et al. titled, “Prevalence and characteristics of patients with progressive supranuclear palsy (PSP) in US health insurance claims data”, crude prevalence of PSP was 1.89 per 100,000 and age-standardized prevalence to the US population was 2.95 per 100,000. A little over half (53.5%) of patients were male.

The study titled “The prevalence of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) in the UK” by Nath et al. estimated that the prevalence of PSP in the UK was 1.0 per 100,000. The age-adjusted standardized prevalence figure for PSP from this study was observed to be 5.0.

According to the National Institute of Neurological Disorders and Stroke, males are affected more as compared to females, in case of PSP,

 

Visit For Sample Pages: 

https://www.delveinsight.com/sample-request/progressive-supranuclear-palsy-market

 

Key Benefits of Progressive Supranuclear Palsy Market Report

Progressive Supranuclear Palsy market report provides an in-depth analysis of Progressive Supranuclear Palsy Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.

The Progressive Supranuclear Palsy market report will help in developing business strategies by understanding the Progressive Supranuclear Palsy Market trends & developments, key players and future market competition that will shape and drive the Progressive Supranuclear Palsy market in the upcoming years.

The Progressive Supranuclear Palsy market report covers Progressive Supranuclear Palsy current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

The report provides a detailed assessment of the Progressive Supranuclear Palsy market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

 

Progressive Supranuclear Palsy Market

The Progressive Supranuclear Palsy market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Progressive Supranuclear Palsy market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. 

 The report gives a thorough detail of Progressive Supranuclear Palsy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. 

Progressive Supranuclear Palsy Epidemiology

The Progressive Supranuclear Palsy epidemiology section covers insights about historical and current Progressive Supranuclear Palsy patient pool and forecasted trend for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

 It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

 

Progressive Supranuclear Palsy Drugs Uptake and Key Market Players

Progressive Supranuclear Palsy Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Progressive Supranuclear Palsy market or expected to get launched in the market during the study period. The analysis covers Progressive Supranuclear Palsy market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions. 

Some of the Emerging therapies in Progressive Supranuclear Palsy Market include AZP2006, UCB0107, ASN120290, and many others.

Key players in Progressive Supranuclear Palsy Market include AlzProtect, UCB Biopharma, TauRx Pharmaceuticals, Asceneuron Therapeutics, EmeraMed, and others

 

Table of Content

1. Key Insights

2. Executive Summary 

3. Progressive Supranuclear Palsy Competitive Intelligence Analysis

4. Progressive Supranuclear Palsy Market Overview at a Glance

5. Progressive Supranuclear Palsy Disease Background and Overview

6. Progressive Supranuclear Palsy Patient Journey

7. Progressive Supranuclear Palsy Epidemiology and Patient Population

8. Progressive Supranuclear Palsy Treatment Algorithm, Current Treatment, and Medical Practices

9. Progressive Supranuclear Palsy Unmet Needs

10. Key Endpoints of Progressive Supranuclear Palsy Treatment

11. Progressive Supranuclear Palsy Marketed Products

12. Progressive Supranuclear Palsy Emerging Therapies

13. Progressive Supranuclear Palsy Seven Major Market Analysis

14. Attribute Analysis

15. Progressive Supranuclear Palsy Market Outlook (7 major markets)

16. Progressive Supranuclear Palsy Access and Reimbursement Overview

17. KOL Views on the Progressive Supranuclear Palsy Market.

18. Progressive Supranuclear Palsy Market Drivers

19. Progressive Supranuclear Palsy Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Related Articles